Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Luna Fit
Oak review
A compounded program sold as one-off packages rather than a subscription, in Spanish as well as English, charging $200/mo for semaglutide and $250 for tirzepatide at one flat rate per dose — but its own pages give nine different starting figures, none carrying a term and none of them the price it actually charges, plus two different answers on how many states it serves.
- Semaglutide
- $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning
- Tirzepatide
- $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning
- Coverage
- No state list published — Oak's own checkout accepts all 50 states and DC; its Terms of Use say 45
- Brand-name
- Compounded only
The Luna Fit scorecard
Oak scored on our six women's-health factors. See the methodology.
What we like
- No membership or subscription fee and no plan to manage — Oak sells one-month and three-month packages, with shipping included
- Oak's own checkout currently accepts every state and Washington D.C., and the site and the intake are offered in Spanish as well as English
- There is no recurring charge to stop, so there is nothing to cancel and no auto-renewal to catch you out
The caveats
- Oak does not publish a price you can act on. Across its own pages it gives nine different "starting" figures — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or a billing cadence to none of them
- The two cheapest of those figures are not monthly rates. "Semaglutide from $119 / Tirzepatide from $185" appears only beside a "$200 off — new patient offer", and Oak's own affiliate page defines that offer as "$50 off your first month, $200 off 3-months" — a three-month package discount printed as if it were a per-month price
- The undiscounted floors Oak itself publishes are $190/mo on its weight-loss page and $167/mo in the comparison table on its homepage, and those two do not agree with each other either
- Its advertising and its order form disagree: none of the nine "starting" figures Oak markets is the $200/$250 it actually charges, so weighing Oak against this ranking on its advertised numbers compares it against a price it does not offer
- Oak advertises that all doses are the same price. We could not confirm it — a reading of its own checkout copy recorded each dose step costing roughly $50 to $75 more — and because the ladder is behind the intake, neither version can be checked from the outside. Treat it as Oak's claim rather than a settled fact
- Oak gives two different answers on where it operates. Its Terms of Use say it provides its services "to 45 states of the U.S.", while the badges on its employer page say all 50 — and its checkout, the only place an actual list exists, currently accepts every state and D.C.
- Those same Terms make you ineligible unless you are in the "States Where We Currently Operate listed at our FAQ section of our Website" — and that list is not on the site. No FAQ on any page asks where Oak operates, so there is nowhere to check your own state before you start the intake
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- No brand-name path and no oral or sublingual route
- Same-day approval with no video call required — fast, but it means little clinical contact before a prescription
- No published lab or monitoring program, and no women's-health-specific framing
The bottom line
Best for: Women who would rather buy a package outright than manage a recurring plan, and who are willing to complete a long health intake before finding out what they will actually be charged. A compounded program sold as one-off packages rather than a subscription, in Spanish as well as English, charging $200/mo for semaglutide and $250 for tirzepatide at one flat rate per dose — but its own pages give nine different starting figures, none carrying a term and none of them the price it actually charges, plus two different answers on how many states it serves.
Ranked #53 of 71 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Price transparency is where Oak scores lowest, at 42/100. If that is your sticking point, start with the alternatives to Oak we rank for women.
Others in Oak's score range
The providers scoring closest to Oak on the same six factors. One of those comparisons is written out in full: how Oak and CoreAge Rx compare on the Luna Fit Score, 21 points apart on the Luna Fit Score. Directly below Oak sits SkinnyRx at #54 with 71/100 — see the full field we rank against SkinnyRx if that is the band you are shopping in.
See all 71 providers we've reviewed for women — ranked on the same rubric, with scores and pricing side by side.
Pricing, states and verification reflect Oak's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on Oak's site. Not medical advice; see our disclosure.